Ligandal, Inc
Ligandal is a pioneering company based in San Francisco, CA, that is revolutionizing the field of precision genetic medicine by solving the complex delivery problem of advanced therapies. Through the development of cell- and tissue-specific delivery technologies using synthetic peptides as targeting modalities, Ligandal is creating the next generation of targeted therapies, including gene therapies and gene editors like CRISPR and mRNA.
Combining machine learning models, peptide chemistry, nanotechnology, and biological studies, Ligandal's innovative approach allows for the rapid discovery, design, and development of novel peptide therapeutics and delivery systems. With a strong foundation of 10 years of research and development efforts and an extensive patent portfolio, Ligandal is at the forefront of computational biology, machine learning, and AI in the realm of nanomaterials and delivery technologies, aiming to advance precision medicine for the betterment of global health and longevity.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.